Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide

855 views
760 views

Published on

Renub Research report titled "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 232 page report with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical Cancer Test Market & Population. All the 20 countries in the report have been studied from 3 viewpoints.

1. Cervical cancer Test Population (2007-2020)

• Pap smear test population (2007-2020)
• HPV DNA test population (2007-2020)
• VIA test Population (2007-2020)

2. Cervical Cancer Mortality Population (2001-2011)

3. Cervical Cancer Test Market (2007-2020)

• Pap smear test market (2007-2020)
• HPV DNA test market (2007-2020)
• VIA test market (2007-2020)

All the 20 Countries studied in the report are as follows

1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. Australia
17. India
18. China
19. Thailand
20. Indonesia

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Click here to view the report Details: http://renub.com/report/cervical-cancer-test-market-patients---pap-smear-hpv-dna-via---test-patients---worldwide-131

For more information visit: http://www.renub.com/


Contact Us

Ankit Mishra
Sr. Manager - Publisher Relation
Sales & Marketing Div.
Renub Research
Email: info@renub.com
Phone: +1-678-302-0700 (USA) , +91-120-4219-822, +91-120-254-5750 (India)
Web: http://www.renub.com/

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
855
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
10
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide

  1. 1. Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide Renub Research www.renub.com Published: April, 2014 Copyright © 2014 Renub Research – All Rights Reserved
  2. 2. Cervical Cancer Test Market Overview Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test. Cervical cancer test market is dominated by United States in 2013. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervical cancer test market in the case of developing countries like India and China. A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual cases, a rising number of organized cervical cancer programs initiated by governments and NGOs and introduction of low cost VIA test are some of the major growth drivers for the cervical cancer test market. However, lack of insufficient healthcare infrastructure and lack of cervical cancer screening awareness are the major hinder for cervical testing market. Renub Research report titled "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 232 page report with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical Cancer Test Market & Population. All the 20 countries in the report have been studied from 3 viewpoints. 1. Cervical cancer Test Population (2007-2020)  Pap smear test population (2007-2020)  HPV DNA test population (2007-2020)  VIA test Population (2007-2020) 2. Cervical Cancer Mortality Population (2001-2011)
  3. 3. 3. Cervical Cancer Test Market (2007-2020)  Pap smear test market (2007-2020)  HPV DNA test market (2007-2020)  VIA test market (2007-2020) All the 20 Countries studied in the report are as follows 1. United Kingdom 2. France 3. Germany 4. Italy 5. Spain 6. Sweden 7. Switzerland 8. Norway 9. Netherlands 10.United States 11.Canada 12.Japan 13.Korea 14.Singapore 15.Malaysia 16.Australia 17.India 18.China 19.Thailand 20.Indonesia
  4. 4. © Renub Research Page 4 of 24 Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and non- printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
  5. 5. © Renub Research Page 5 of 24 About Us RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets. For more information on us or to view any of our sample work you can mail us at info@renub.com
  6. 6. © Renub Research Page 6 of 24 Published By RReennuubb RReesseeaarrcchh 1st Floor, C-86, Sector–10 Noida – 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com © Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide Renub Research, 2014 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers
  7. 7. © Renub Research Page 7 of 24 Table of Contents 1. Executive Summary 2. Worldwide Cervical Cancer Test (Screening) Population & Forecast 3. Worldwide Cervical Cancer Test (Screening) Market & Forecast 3.1 Worldwide Cervical Cancer Pap Smear Test (Screening) Market & Forecast 3.2 Worldwide Cervical Cancer HPV DNA Test (Screening) Market & Forecast 3.3 Worldwide - Cervical Cancer Visual Inspection with Acetic Acid (VIA) Test (Screening) Market & Forecast 4. Worldwide Cervical Cancer Test (Screening) Population Share, Market Share & Forecast 4.1 Worldwide Cervical Cancer Test (Screening) Population Share & Forecast 4.2 Worldwide Cervical Cancer Test (Screening) Market Share & Forecast 4.3 Worldwide Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast 4.4 Worldwide Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast 4.5 Worldwide Cervical Cancer VIA Test (Screening) Market Share & Forecast 5. United Kingdom – Cervical Cancer Test Analysis 5.1 United Kingdom Cervical Cancer Test (Screening) Population 5.1.1 United Kingdom Cervical Cancer Pap Smear Test Population & Forecast 5.1.2 United Kingdom Cervical Cancer HPV DNA Test Population & Forecast 5.2 United Kingdom Cervical Cancer Mortality 5.3 United Kingdom Cervical Cancer Test (Screening) Analysis 5.3.1 United Kingdom Cervical Cancer Test Market & Forecast 5.3.2 United Kingdom Pap Smear Test Market & Forecast 5.3.3 United Kingdom HPV DNA Test Market & Forecast 6. France – Cervical Cancer Test Analysis 6.1 France Cervical Cancer Test (Screening) Population 6.1.1 France Cervical Cancer Pap Smear Test Population & Forecast 6.1.2 France Cervical Cancer HPV DNA Test Population & Forecast 6.2 France Cervical Cancer Mortality 6.3 France Cervical Cancer Test (Screening) Analysis
  8. 8. © Renub Research Page 8 of 24 6.3.1 France Cervical Cancer Test Market & Forecast 6.3.2 France Pap Smear Test Market & Forecast 6.3.3 France HPV DNA Test Market & Forecast 7. Germany – Cervical Cancer Test Analysis 7.1 Germany Cervical Cancer Test (Screening) Population 7.1.1 Germany Cervical Cancer Pap Smear Test Population & Forecast 7.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast 7.2 Germany Cervical Cancer Mortality 7.3 Germany Cervical Cancer Test (Screening) Market 7.3.1 Germany Cervical Cancer Test Market & Forecast 7.3.2 Germany Pap Smear Test Market & Forecast 7.3.3 Germany HPV DNA Test Market & Forecast 8. Italy – Cervical Cancer Test Analysis 8.1 Italy Cervical Cancer Test (Screening) Population 8.1.1 Italy Cervical Cancer Pap Smear Test Population & Forecast 8.1.2 Italy Cervical Cancer HPV DNA Test Population & Forecast 8.2 Italy Cervical Cancer Mortality 8.3 Italy Cervical Cancer Test (Screening) Market 8.3.1 Italy Cervical Cancer Test Market & Forecast 8.3.2 Italy Pap Smear Test Market & Forecast 8.3.3 Italy HPV DNA Test Market & Forecast 9. Spain – Cervical Cancer Test Analysis 9.1 Spain Cervical Cancer Test (Screening) Population 9.1.1 Spain Cervical Cancer Pap Smear Test Population & Forecast 9.1.2 Spain Cervical Cancer HPV DNA Test Population & Forecast 9.2 Spain Cervical Cancer Mortality 9.3 Spain Cervical Cancer Test (Screening) Market 9.3.1 Spain Cervical Cancer Test Market & Forecast 9.3.2 Spain Pap Smear Test Market & Forecast 9.3.3 Spain HPV DNA Test Market & Forecast 10. Sweden – Cervical Cancer Test Analysis 10.1 Sweden Cervical Cancer Test (Screening) Population 10.1.1 Sweden Cervical Cancer Pap Smear Test Population & Forecast
  9. 9. © Renub Research Page 9 of 24 10.1.2 Sweden Cervical Cancer HPV DNA Test Population & Forecast 10.2 Sweden Cervical Cancer Mortality 10.3 Sweden Cervical Cancer Test (Screening) Market 10.3.1 Sweden Cervical Cancer Test Market & Forecast 10.3.2 Sweden Pap Smear Test Market & Forecast 10.3.3 Sweden HPV DNA Test Market & Forecast 11. Switzerland – Cervical Cancer Test Analysis 11.1 Switzerland Cervical Cancer Test (Screening) Population 11.1.1 Switzerland Cervical Cancer Pap Smear Test Population & Forecast 11.1.2 Switzerland Cervical Cancer HPV DNA Test Population & Forecast 11.2 Switzerland Cervical Cancer Mortality 11.3 Switzerland Cervical Cancer Test (Screening) Market 11.3.1 Switzerland Cervical Cancer Test Market & Forecast 11.3.2 Switzerland Pap smear Test Market & Forecast 11.3.3 Switzerland HPV DNA Test Market & Forecast 12. Norway – Cervical Cancer Test Analysis 12.1 Norway Cervical Cancer Test (Screening) Population 12.1.1 Norway Cervical Cancer Pap Smear Test Population & Forecast 12.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast 12.2 Norway Cervical Cancer Mortality 12.3 Norway Cervical Cancer Test (Screening) Market 12.3.1 Norway Cervical Cancer Test Market & Forecast 12.3.2 Norway Pap Smear Test Market & Forecast 12.3.3 Norway HPV DNA Test Market & Forecast 13. Netherlands – Cervical Cancer Test Analysis 13.1 Netherlands Cervical Cancer Test (Screening) Population 13.1.1 Netherlands Cervical Cancer Pap Smear Test Population & Forecast 13.1.2 Netherlands Cervical Cancer HPV DNA Test Population & Forecast 13.2 Netherlands Cervical Cancer Mortality 13.3 Netherlands Cervical Cancer Test (Screening) Market 13.3.1 Netherlands Cervical Cancer Test Market & Forecast 13.3.2 Netherlands Pap Smear Test Market & Forecast 13.3.3 Netherlands HPV DNA Test Market & Forecast
  10. 10. © Renub Research Page 10 of 24 14. United States – Cervical Cancer Test Analysis 14.1 United States Cervical Cancer Test (Screening) Population 14.1.1 United States Cervical Cancer Pap Smear Test Population & Forecast 14.1.2 United States Cervical Cancer HPV DNA Test Population & Forecast 14.2 United States Cervical Cancer Mortality 14.3 United States Cervical Cancer Test (Screening) Market 14.3.1 United States Cervical Cancer Test Market & Forecast 14.3.2 United States Pap smear Test Market & Forecast 14.3.3 United States HPV DNA Test Market & Forecast 15. Canada – Cervical Cancer Test Analysis 15.1 Canada Cervical Cancer Test (Screening) Population 15.1.1 Canada Cervical Cancer Pap Smear Test Population & Forecast 15.1.2 Canada Cervical Cancer HPV DNA Test Population & Forecast 15.2 Canada Cervical Cancer Mortality 15.3 Canada Cervical Cancer Test (Screening) Market 15.3.1 Canada Cervical Cancer Test Market & Forecast 15.3.2 Canada Pap Smear Test Market & Forecast 15.3.3 Canada HPV DNA Test Market & Forecast 16. Japan – Cervical Cancer Test Analysis 16.1 Japan Cervical Cancer Test (Screening) Population 16.1.1 Japan Cervical Cancer Pap Smear Test Population & Forecast 16.1.2 Japan Cervical Cancer HPV DNA Test Population & Forecast 16.2 Japan Cervical Cancer Mortality 16.3 Japan Cervical Cancer Test (Screening) Market 16.3.1 Japan Cervical Cancer Test Market & Forecast 16.3.2 Japan Pap Smear Test Market & Forecast 16.3.3 Japan HPV DNA Test Market & Forecast 17. South Korea – Cervical Cancer Tests Analysis 17.1 South Korea - Cervical Cancer Test (Screening) Population 17.1.1 South Korea - Cervical Cancer Pap Smear Test Population & Forecast 17.1.2 Korea Cervical Cancer HPV DNA Test Population & Forecast 17.2 Korea Cervical Cancer Mortality
  11. 11. © Renub Research Page 11 of 24 17.3 Korea Cervical Cancer Test (Screening) Market 17.3.1 Korea Cervical Cancer Test Market & Forecast 17.3.2 Korea Pap Smear Test Market & Forecast 17.3.3 Korea HPV DNA Test Market & Forecast 18. Singapore – Cervical Cancer Tests Analysis 18.1 Singapore - Cervical Cancer Test (Screening) Population 18.1.1 Singapore - Cervical Cancer Pap Smear Test Population & Forecast 18.1.2 Singapore Cervical Cancer HPV DNA Test Population & Forecast 18.2 Singapore Cervical Cancer Test (Screening) Market 18.2.1 Singapore Cervical Cancer Test Market & Forecast 18.2.2 Singapore Pap Smear Test Market & Forecast 18.2.3 Singapore HPV DNA Test Market & Forecast 19. Malaysia – Cervical Cancer Test Analysis 19.1 Malaysia - Cervical Cancer Test (Screening) Population 19.1.1 Malaysia Cervical Cancer Pap Smear Test Population & Forecast 19.1.2 Malaysia Cervical Cancer HPV DNA Test Population & Forecast 19.2 Malaysia Cervical Cancer Test (Screening) Market 19.2.1 Malaysia Cervical Cancer Test Market & Forecast 19.2.2 Malaysia Pap Smear Test Market & Forecast 19.2.3 Malaysia HPV DNA Test Market & Forecast 20. Australia – Cervical Cancer Test Analysis 20.1 Australia - Cervical Cancer Test (Screening) Population 20.1.1 Australia Cervical Cancer Pap Smear Test Population & Forecast 20.1.2 Australia Cervical Cancer HPV DNA Test Population & Forecast 20.2 Australia Cervical Cancer Mortality 20.3 Australia Cervical Cancer Test (Screening) Market 20.3.1 Australia Cervical Cancer Test Market & Forecast 20.3.2 Australia Pap Smear Test Market & Forecast 20.3.3 Australia HPV DNA Test Market & Forecast 21. India – Cervical Cancer Test Analysis 21.1 India - Cervical Cancer Test (Screening) Population 21.1.1 India Cervical Cancer Pap Smear Test Population & Forecast 21.1.2 India Cervical Cancer HPV DNA Test Population & Forecast
  12. 12. © Renub Research Page 12 of 24 21.1.3 India Cervical Cancer VIA Test Population & Forecast 21.2 India Cervical Cancer Test (Screening) Market 21.2.1 India Cervical Cancer Test Market & Forecast 21.2.2 India Pap Smear Test Market & Forecast 21.2.3 India HPV DNA Test Market & Forecast 21.2.4 India VIA Test Market & Forecast 22. China – Cervical Cancer Test Analysis 22.1 China - Cervical Cancer Test (Screening) Population 22.1.1 China Cervical Cancer Pap smear Test Population & Forecast 22.1.2 China Cervical Cancer HPV DNA Test Population & Forecast 22.1.3 China Cervical Cancer VIA Test Population & Forecast 22.2 China - Cervical Cancer Test (Screening) Market 22.2.1 China Cervical Cancer Test Market & Forecast 22.2.2 China Pap Smear Test Market & Forecast 22.2.3 China HPV DNA Test Market & Forecast 22.2.4 China VIA Test Market & Forecast 23. Thailand – Cervical Cancer Test Analysis 23.1 Thailand - Cervical Cancer Test (Screening) Population 23.1.1 Thailand Cervical Cancer Pap Smear Test Population & Forecast 23.1.2 Thailand Cervical Cancer VIA Test Population & Forecast 23.2 Thailand Cervical Cancer Test (Screening) Market 23.2.1 Thailand Cervical Cancer Test Market & Forecast 23.2.2 Thailand Pap smear Test Market & Forecast 23.2.3 Thailand VIA Test Market & Forecast 24. Indonesia – Cervical Cancer Test Analysis 24.1 Indonesia Cervical Cancer Test (Screening) Population 24.1.1 Indonesia Cervical Cancer Pap Smear Test Population & Forecast 24.1.2 Indonesia Cervical Cancer HPV DNA Test Population & Forecast 24.1.3 Indonesia Cervical Cancer VIA Test Population & Forecast 24.1.4 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Population & Forecast 24.2 Indonesia Cervical Cancer Test (Screening) Market 24.2.1 Indonesia Cervical Cancer Test Market & Forecast 24.2.2 Indonesia Pap smear Test Market & Forecast 24.2.3 Indonesia HPV DNA Test Market & Forecast
  13. 13. © Renub Research Page 13 of 24 24.2.4 Indonesia VIA Test Market & Forecast 24.2.5 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Market & Forecast 25. Cervical Cancer Test Market Growth Drivers 25.1 Point No. 1 25.2 Point No. 2 25.3 Point No. 3 26. Challenges in Cervical Cancer Test Market 26.1 Point No. 1 26.2 Point No. 2
  14. 14. © Renub Research Page 14 of 24 List of Figures: Figure 2-1: Worldwide – Cervical Cancer Test Population (Million), 2005 – 2013 Figure 2-2: Worldwide – Forecast for Cervical Cancer Test Population (Million), 2014 – 2020 Figure 3-1: Worldwide – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 3-2: Worldwide – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 3-3: Worldwide – Cervical Cancer Pap Smear Test Market (Million US$), 2005 – 2013 Figure 3-4: Worldwide – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2014 – 2020 Figure 3-5: Worldwide – Cervical Cancer HPV DNA Test Market (Million US$), 2005 – 2013 Figure 3-6: Worldwide – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2014 – 2020 Figure 3-7: Worldwide – Cervical Cancer VIA Test Market (Million US$), 2005 – 2013 Figure 3-8: Worldwide – Forecast for Cervical Cancer VIA Test Market (Million US$), 2014 – 2020 Figure 5-1: United Kingdom – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 5-2: United Kingdom – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 5-3: United Kingdom – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 5-4: United Kingdom – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 5-5: United Kingdom – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 5-6: United Kingdom – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 5-7: United Kingdom – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 5-8: United Kingdom – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 5-9: United Kingdom – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 5-10: United Kingdom – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 5-11: United Kingdom – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 6-1: France – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 6-2: France – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 6-3: France – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 6-4: France – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 6-5: France – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 6-6: France – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 6-7: France – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 6-8: France – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 6-9: France – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 6-10: France – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 6-11: France – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 7-1: Germany – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013
  15. 15. © Renub Research Page 15 of 24 Figure 7-2: Germany – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 7-3: Germany – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 7-4: Germany – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 7-5: Germany – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 7-6: Germany – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 7-7: Germany – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 7-8: Germany – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 7-9: Germany – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 7-10: Germany – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 7-11: Germany – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 8-1: Italy – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 8-2: Italy – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 8-3: Italy – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 8-4: Italy – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 8-5: Italy – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 8-6: Italy – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 8-7: Italy – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 8-8: Italy – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 8-9: Italy – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 8-10: Italy – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 8-11: Italy – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 9-1: Spain – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 9-2: Spain – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 9-3: Spain – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 9-4: Spain – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 –2020 Figure 9-5: Spain – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 9-6: Spain – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 9-7: Spain – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 9-8: Spain – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 9-9: Spain – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 9-10: Spain – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 9-11: Spain – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 10-1: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 10-2: Sweden – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 10-3: Sweden – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 10-4: Sweden – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 10-5: Sweden – Cervical Cancer Mortality (Number), 2001 – 2011
  16. 16. © Renub Research Page 16 of 24 Figure 10-6: Sweden – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 10-7: Sweden – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 10-8: Sweden – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 10-9: Sweden – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 10-10: Sweden – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 10-11: Sweden – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 11-1: Switzerland – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 11-2: Switzerland – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 11-3: Switzerland – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 11-4: Switzerland – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 11-5: Switzerland – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 11-6: Switzerland – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 11-7: Switzerland – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 11-8: Switzerland – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 11-9: Switzerland – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 11-10: Switzerland – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 11-11: Switzerland – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 12-1: Norway – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 12-2: Norway – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 12-3: Norway – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 12-4: Norway – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 12-5: Norway – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 12-6: Norway – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 12-7: Norway – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 12-8: Norway – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 12-9: Norway – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 12-10: Norway – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 12-11: Norway – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 13-1: Netherlands – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 13-2: Netherlands – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 13-3: Netherlands – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 13-4: Netherlands – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 13-5: Netherlands – Cervical Cancer Mortality (Number), 2001 – 2011
  17. 17. © Renub Research Page 17 of 24 Figure 13-6: Netherlands – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 13-7: Netherlands – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 13-8: Netherlands – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 13-9: Netherlands – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 13-10: Netherlands – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 13-11: Netherlands – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 14-1: United States – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 14-2: United States – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 14-3: United States – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 14-4: United States – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 14-5: United States – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 14-6: United States – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 14-7: United States – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 14-8: United States – Pap smear Test Market (Million US$), 2005 – 2013 Figure 14-9: United States – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 14-10: United States – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 14-11: United States – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 15-1: Canada – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 15-2: Canada – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 15-3: Canada – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 15-4: Canada – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 15-5: Canada – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 15-6: Canada – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 15-7: Canada – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 15-8: Canada – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 15-9: Canada – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 15-10: Canada – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 15-11: Canada – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 16-1: Japan – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 16-2: Japan – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 16-3: Japan – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 16-4: Japan – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 16-5: Japan – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 16-6: Japan – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 16-7: Japan – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020
  18. 18. © Renub Research Page 18 of 24 Figure 16-8: Japan – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 16-9: Japan – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 16-10: Japan – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 16-11: Japan – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 17-1: Korea – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 17-2: Korea – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 17-3: Korea – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 17-4: Korea – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 17-5: Korea – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 17-6: Korea – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 17-7: Korea – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 17-8: Korea – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 17-9: Korea – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 17-10: Korea – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 17-11: Korea – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 18-1: Singapore – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 18-2: Singapore – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 18-3: Singapore – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 18-4: Singapore – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 18-5: Singapore – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 18-6: Singapore – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 18-7: Singapore – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 18-8: Singapore – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 18-9: Singapore – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 18-10: Singapore – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 19-1: Malaysia – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 19-2: Malaysia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 19-3: Malaysia – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 19-4: Malaysia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 19-5: Malaysia – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 19-6: Malaysia – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 19-7: Malaysia – Pap smear Test Market (Million US$), 2005 – 2013 Figure 19-8: Malaysia – Forecast for Pap smear Test Market (Million US$), 2014 – 2020 Figure 19-9: Malaysia – HPV DNA Test Market (Million US$), 2005 – 2013
  19. 19. © Renub Research Page 19 of 24 Figure 19-10: Malaysia – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 20-1: Australia – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 20-2: Australia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 20-3: Australia – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 20-4: Australia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 20-5: Australia – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 20-6: Australia – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 20-7: Australia – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 20-8: Australia – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 20-9: Australia – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 20-10: Australia – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 20-11: Australia – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 21-1: India – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 21-2: India – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 21-3: India – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 21-4: India – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 21-5: India – Cervical Cancer VIA Test Population (Thousand), 2005 – 2013 Figure 21-6: India – Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 – 2020 Figure 21-7: India – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 21-8: India – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 21-9: India – Pap smear Test Market (Million US$), 2005 – 2013 Figure 21-10: India – Forecast for Pap smear Test Market (Million US$), 2014 – 2020 Figure 21-11: India – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 21-12: India – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 21-13: India – VIA Test Market (Million US$), 2005 – 2013 Figure 21-14: India – Forecast for VIA Test Market (Million US$), 2014 – 2020 Figure 22-1: China – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 22-2: China – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 22-3: China – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 22-4: China – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 22-5: China – Cervical Cancer VIA Test Population (Thousand), 2005 – 2013 Figure 22-6: China – Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 – 2020 Figure 22-7: China – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 22-8: China – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 22-9: China – Pap smear Test Market (Million US$), 2005 – 2013 Figure 22-10: China – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020
  20. 20. © Renub Research Page 20 of 24 Figure 22-11: China – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 22-12: China – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 22-13: China – VIA Test Market (Million US$), 2005 – 2013 Figure 22-14: China – Forecast for VIA Test Market (Million US$), 2014 – 2020 Figure 23-1: Thailand – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 23-2: Thailand – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 23-3: Thailand – Cervical Cancer VIA Test Population (Thousand), 2005 – 2013 Figure 23-4: Thailand – Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 – 2020 Figure 23-5: Thailand – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 23-6: Thailand – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 23-7: Thailand – Pap smear Test Market (Million US$), 2005 – 2013 Figure 23-8: Thailand – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 23-9: Thailand – VIA Test Market (Million US$), 2005 – 2013 Figure 23-10: Thailand – Forecast for VIA Test Market (Million US$), 2014 – 2020 Figure 24-1: Indonesia – Cervical Cancer Pap Smear Test Population (Thousand), 2005 – 2013 Figure 24-2: Indonesia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2020 Figure 24-3: Indonesia – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 24-4: Indonesia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 24-5: Indonesia – Cervical Cancer VIA Test Population (Thousand), 2005 – 2013 Figure 24-6: Indonesia – Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 – 2020 Figure 24-7: Indonesia – Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2005 – 2013 Figure 24-8: Indonesia – Forecast for Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2014 – 2020 Figure 24-9: Indonesia – Cervical Cancer Test Market (Million US$), 2005 – 2013 Figure 24-10: Indonesia – Forecast for Cervical Cancer Test Market (Million US$), 2014 – 2020 Figure 24-11: Indonesia – Pap Smear Test Market (Million US$), 2005 – 2013 Figure 24-12: Indonesia – Forecast for Pap Smear Test Market (Million US$), 2014 – 2020 Figure 24-13: Indonesia – HPV DNA Test Market (Million US$), 2005 – 2013 Figure 24-14: Indonesia – Forecast for HPV DNA Test Market (Million US$), 2014 – 2020 Figure 24-15: Indonesia – VIA Test Market (Million US$), 2005 – 2013 Figure 24-16: Indonesia – Forecast for VIA Test Market (Million US$), 2014 – 2020 Figure 24-17: Indonesia – Both (Pap smear & VIA) Test Market (Million US$), 2005 – 2013 Figure 24-18: Indonesia – Forecast for Both (Pap Smear & VIA) Test Market (Million US$), 2014 – 2020
  21. 21. © Renub Research Page 21 of 24 List of Tables: Table 4-1: Worldwide – Cervical Cancer Test Population Share (Percent), 2005 – 2013 Table 4-2: Worldwide – Forecast for Cervical Cancer Test Population Share (Percent), 2014 – 2020 Table 4-3: Worldwide – Cervical Cancer Test Market Share (Percent), 2005 – 2013 Table 4-4: Worldwide – Forecast for Cervical Cancer Test Market Share (Percent), 2014 – 2020 Table 4-5: Worldwide – Cervical Cancer Pap Smear Test Market Share (Percent), 2005 – 2013 Table 4-6: Worldwide – Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2014 – 2020 Table 4-7: Worldwide – Cervical Cancer HPV DNA Test Market Share (Percent), 2005 – 2013 Table 4-8: Worldwide – Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2014 – 2020 Table 4-9: Worldwide – Cervical Cancer VIA Test Market Share (Percent), 2005 – 2013 Table 4-10: Worldwide – Forecast for Cervical Cancer VIA Test Market Share (Percent), 2014 – 2020 Table 25-1: Worldwide – List of Countries which offer VIA Test via National Programs, 2010 Table 25-2: Worldwide – List of Countries which offer VIA Test via Pilot Programs, 2010 Table 25-3: Worldwide – Prevalence (Percent) of Young Women (15–44 Years) who Have Sex before the Age of 15 Years, 1994 – 2006 Table 25-4: Worldwide – HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010
  22. 22. © Renub Research Page 22 of 24 Order Form Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com Format Report Title: Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide Single User (Email from Publisher) Hard Copy (Mail Delivery) CD – Rom (Mail Delivery) Global Site License (Multiple User License) US$ 1,490 US$ 1,790 US$ 1,590 US$ 2,300 For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/cervical-cancer-test-market-patients---pap-smear-hpv-dna-via- --test-patients---worldwide-131 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=131&pid=1521 To pay by Wire Transfer, please, fill in your contact details in the form below:
  23. 23. © Renub Research Page 23 of 24 Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India Contact Information First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:
  24. 24. © Renub Research Page 24 of 24 3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor C-86, Sector -10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA) Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

×